skip to content
Long-term effects of neuroleptics Preview this item
ClosePreview this item
Checking...

Long-term effects of neuroleptics

Author: Flaminio Cattabeni; Fondazione internazionale Menarini.
Publisher: New York : Raven Press, ©1980.
Series: Advances in biochemical psychopharmacology, v. 24.
Edition/Format:   Print book : Conference publication : EnglishView all editions and formats
Database:WorldCat
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Congresses
Conference proceedings
Conference papers and proceedings
Congrès
Material Type: Conference publication
Document Type: Book
All Authors / Contributors: Flaminio Cattabeni; Fondazione internazionale Menarini.
ISBN: 0890044058 9780890044056
OCLC Number: 6221899
Notes: Proceedings of a symposium held in Monte Carlo in March 1979, sponsored by the Menarini International Foundation, Milan, Italy.
Description: xxxii, 619 pages : illustrations ; 24 cm.
Contents: Regulation of tyrosine hydroxylase after chronic treatment with classical and atypical antischizophrenic drugs / A. Guidotti --
Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase / W. Lovenberg, L. Alphs, S. Pradhan, E. Bruckwick, and R. Levine --
Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors / G. Biggio, M. Casu, V. Klimek, and G.L. Gessa --
Effects of chronic neuroleptic treatment on tyrosine-hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance / Karen Gale --
Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain / B. Scatton --
Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity / Maurizio Raiteri, Franca Cerrito, Gianna Casazza, and Giulio Levi --
Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment / G. Racagni, F. Bruno, A. Bugatti, M. Parenti, J.A. Apud, V. Santini, A. Carenzi, A. Groppetti, and F. Cattabeni. Changes in cerebral dopamine metabolism and receptors during one year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia / A. Clow, P. Jenner, A. Theodorou, and C.D. Marsden --
Drug effects on pre- and postsynaptic dopamine receptors / Nils-Erik Anden and Maria Grabowska-Anden --
Adaptive changes of the striatal dopamine system induced by repeated adminstration of neuroleptics and ergot derivatives / H.R. Burki --
Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists / Pavel Muller, Torgny H. Svensson, and Arvid Carlsson --
Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal rich areas / L.F. Agnati, K. Andersson, K. Fuxe, F. Benfenati, P. Cortelli, R. D'Alessandro, and S.-O. Ogren --
Dopamine receptor: from synaptic membranes to solubilization / Pierre Laduron --
Chronic neuroleptic treatment and dopamine receptor regulation / Ian Creese and Solomon H. Snyder --
Neuroleptic/dopamine receptors: elevation and reversal Stephen List and Philip Seeman --
Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment / Yvonne Clement-Cormier --
Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS / P.F. Spano, M. Memo, S. Govoni, and M. Trabucchi. 3H-apomorphine receptors in various rat brain regions: a study of specific and non-specific binding and the influence of chronic neuroleptic treatment / Josee E. Leysen --
Involvement of calmodulin in the modulation of dopamine receptor function / I. Hanbauer and W. Phyall --
Modulation of [beta]-adrenergic receptors and calmodulin following acute and chronic treatment with neuroleptics / Benjamin Weiss and Louise H. Greenberg --
Calmodulin release from striatal membranes after acute and chronic treatment owth butaclamol / M.E. Gnegy and Y.S. Lau --
Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs / Alice M. Marshall nd Ram K. Mishra --
Radioreceptor labeling of pre- and post-synaptic dopamine receptors / Milt Titeler and Philip Seeman --
No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics / John Hyttel --
Dopamine receptor blockade in rat brain after acute and subchronic treatment with tricyclic antidepressants / H.H. Keller, W.P. Burkard, and M. Da Prada --
Attempts to develop super- or subsensitivity of retinal dopamine receptors after various treatments in antagonists or agonists / Pierre J. Magistretti and Michel Schorderet. Kainic acid and neurotransmitter interactions in the basal ganglia / P.L. McGeer, E.G. McGeer, and V.T. Innanen --
Effects of chronic treatment with 1-sulpiride and haloperidol on central monoaminergic mechanisms / Kjell Fuxe, Sven-Ove Ogren, Hakan Hall, Luigi F. Agnati, Kurt Andersson, Christer Kohler, and R. Schwarcz --
Effect of the new gamma --
aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations / C. Bartholini, B. Scatton, and B. Zivkovic --
Rapid development of hypersensitivity and hyposensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in CNS / A.R. Cools --
Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons / J.S. Hong, H.-Y.T. Yang, J.C. Gillin, and E. Costa --
The role of gabba --
aminobutyric acid in acute and chronic neuroleptic action / J. Scheel-Kruger and A.V. Christensen --
Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs / F. Moroni, F. Casamenti, S. Caliari, G. Pisani, G. Moneti, and G. Pepeu --
Sustained gabba --
aminobutyric acid receptor stimulation and chronic neuroleptic effects / K.G. Lloyd and P. Worms. Long-term effects of haloperidol, clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics / Herbert Ladinsky, Silvana Consolo, Rosario Samanin, Sergio Algeri, and Franca Ponzio --
Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity / Benjamin S. Bunney, Lana Skirboll, and Anthony A. Grace --
Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors / M. Trabucchi, M. Memo, F. Battaini, A. Reggiani, and P.F. Spano --
Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain / Ram B. Rastogi, Yvon D. Lapierre, Radhey L. Singhal, and N.P.V. Nair --
Long-term application of heloperidol: effect of anticholinergic treatment on the rate of dopamine-synthesis / G. Stock, P. Kummer, and J. Steinbrenner --
Neuropharmacological and neurochemical approaches to preclinical evaluation of neuroleptics / V.V. Zakusov --
The behavioral consequences of long-term treatment with neuroleptic drugs / Susan D. Iversen, R.B. Howells, and R.P. Hughes --
Brain monoamines in the rhesus monkey during long-term neuroleptic administration / Kathleen S. Shannak and Oleh Hornykiewcz --
Dopaminergic abnormalities in post-mortem schizophrenic brain / A.V.P. Mackay, E.D. Bird, L.L. Iversen, E.G. Spokes, I. Creese, and S.H. Snyder --
Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal / A. Clow, A. Theodorou, P. Jenner, and C.D. Marsden. Dopaminergic supersensitivity. Influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia / A.V. Christensen and I. Moller Nielsen --
Behavioral, anti-dopaminergic and pro-hypnotic effects of neuroleptics during and after prolonged treatment / A. Biazzi and G.B. Fregnan --
Anticholinergics promote neuroleptic-induced tardive dyskinesia / Richard L. Borison and Bruce I. Diamond --
Receptor plasticity: biochemical correlates and pharmacological significance / E. Costa --
Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion / Lucio Annunziato, Aldo Quattrone, Gennaro Schettini, and Gianfranco Di Renzo --
Effects of neuroleptics on neuroendocrine mechanisms for gonadotropin secretion / E.E. Muller, G.B. Fregnan, T. Chieli, D. Cocchi, C. Frigerio, and V. Locatelli --
Alteration of prolactin secretion by centrally acting drugs / G.M. Besser, T. Yeo, G. Delitala, and A.B. Grossman --
Long-term effect of neuroleptics on corticosterone septo-hippocampal uptake in rats / L. Angelucci, P. Valeri, M. Palmery, and F. Patacchioli --
Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Relations to psychopathology / Dieter Naber, Manfred Ackenheil, and Gregor Laakmann --
A pharmacological analysis of the role of the amygdala in the control of gonadotropin and prolactin secretion / F. Piva, L. Martini, and M. Motta. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies / N.P.V. Nair, S. Lal, G. Schwartz, and J.X. Thavundayil --
Effect of serotonin on prolactin secretion in vitro / G. Delitala, T. Yeo, W.A. Stubbs, Ann Jones, and G.M. Besser --
Inhibition of sulpiride-induced prolactin secretion by dihydroergocristine in man / M. Poli, F. Caviezel, A.M. Girardi, E. Bosi, and G. Pozza --
The pathophysiologic basis of tardive dyskinesia / Ross J. Baldessarini and Daniel Tarsy --
Pharmacologic studies of tardive dyskinesia / Thomas N. Chase and Carol A. Tamminga --
Use of choline and lecithin in the treatment of tardive dyskinesia / Steven H. Zeisel, Alan J. Gelenberg, John H. Growdon, and Richard J. Wurtman --
Use of survival curves in analysis of antipsychotic relapse studies / John M. Davis, Maurice W. Dysken, Shelby J. Haberman, Javaid I. Javaid, Sidney S. Chang, and Grant A. Killian --
Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study / Jerome Levine, Nina R. Schooler, Joanne Severe, Javier Escobar, Alan Gelenberg, Michel Mandel, Robert Sovner, and Richard Steinbook. Time course of the antipsychotic effect in schizophrenia and some changes in post-mortem brain and their relation to neuroleptic medication / T.J. Crow, A.J. Cross, E.C. Johnstone, A. Longden, F. Owen, and R.M. Ridley --
Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs / Palle Kristjansen --
Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and non-human primates / Robert H. Roth, Nicholas G. Bacopoulos, Gonzalo Bustos, and D. Eugene Redmond, Jr. --
Relationships among biochemical, clinical, and pharmacokinetic variables in neuroleptic treated schizophrenic patients / Goran Sedvall --
Haloperidol plasma levels monitoring in psychiatric patients / P.L. Morselli, E. Zarifian, H. Cuche, G. Bianchetti, M.J. Cotterau, and P. Deniker --
Short- and long-term effects on GABA and dopamine neurons during treatment with sulpiride / R. Zimmer, A.W. Teelken, H. Cramer, M. Ackenheil, K.J. Zander, and H. Fischer. Dopamine antagonist and agonist treatment of tardive dyskinesia / N. Bjorndal, D. Casey, and J. Gerlach --
Factors determining patient tenure on a three year double blind investigation of pimozide vs fluphenazine HCI / F.S. Abuzzahab, Sr. and R.L. Zimmermann --
A neuropharmacological and neurodendocrine study on idiopathic and chronic pharmacological parkinsonism / A. Agnoli, S. Ruggieri, P. Falaschi, M. Baldassarre, R. D'Urso, C. Forchetti, and A. Polleri --
Twelve years' experience with the total use of depot neuroleptics in a defined population / Hugh Freeman --
Reclassification of the tardive dyskinesia syndrome / T.R.E. Barnes, T. Kidger, T. Trauer, and P. Taylor --
Correlation between daily dosage of chlorpromazine and subsequent supersensitivity / Harold L. Klawans, Paul Carvey, Ana Hitri, Paul A. Nausieda, and William J. Weiner --
Huntington's disease: clinical effects of a short-term treatment with pimozide / R. Arena, A. Iudice, P. Virgili, P. Moretti, and G. Menchetti --
[gamma]-acetylenic GABA in tardive dyskinesia / Daniel E. Casey, Jes Gerlach, Gerhard Magelund, and Torben Rosted Christensen. Plasma levels and therapeutic efficacy of fluphenazine hydrochloride and decanoate / Maurice W. Dysken, Sidney S. Chang, Charles Schaffer, Regina C. Casper, Javaid I. Javaid, and John M. Davis --
Measurement of fluphenazine by gas chromatography in human plasma and red blood cells / J.I. Javaid, H. Dekirmenjian, M. Dysken, and J.M. Davis --
Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration / O.T. Phillipson, J. Baker, and M. Williams --
Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate / D.H. Wiles and M.G. Gelder --
Problems of drug treatment of mental disorders / F.E. Vartanian.
Series Title: Advances in biochemical psychopharmacology, v. 24.
Responsibility: editors, F. Cattabeni [and others].

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/6221899> # Long-term effects of neuroleptics
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "6221899" ;
   library:placeOfPublication <http://dbpedia.org/resource/New_York_City> ; # New York
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/111510723#Topic/neuroleptiques_pharmacocinetique_congres_comme_sujet> ; # Neuroleptiques--Pharmacocinétique--Congrès comme sujet
   schema:about <http://id.worldcat.org/fast/1154491> ; # Tranquilizing drugs
   schema:about <http://dewey.info/class/615.7882/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/111510723#Topic/neuropsychopharmacology> ; # Neuropsychopharmacology
   schema:about <http://id.loc.gov/authorities/subjects/sh85136865> ; # Tranquilizing drugs
   schema:about <http://experiment.worldcat.org/entity/work/data/111510723#Topic/neuropsychopharmacologie_congres> ; # Neuropsychopharmacologie--Congrès
   schema:about <http://experiment.worldcat.org/entity/work/data/111510723#Topic/antipsychotic_agents_pharmacology> ; # Antipsychotic Agents--pharmacology
   schema:about <http://id.worldcat.org/fast/1036504> ; # Neuropsychopharmacology
   schema:about <http://experiment.worldcat.org/entity/work/data/111510723#Topic/tranquillisants> ; # Tranquillisants
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://experiment.worldcat.org/entity/work/data/111510723#Person/cattabeni_flaminio> ; # Flaminio Cattabeni
   schema:contributor <http://viaf.org/viaf/155405496> ; # Fondazione internazionale Menarini.
   schema:copyrightYear "1980" ;
   schema:datePublished "1980" ;
   schema:description "Dopaminergic supersensitivity. Influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia / A.V. Christensen and I. Moller Nielsen -- Behavioral, anti-dopaminergic and pro-hypnotic effects of neuroleptics during and after prolonged treatment / A. Biazzi and G.B. Fregnan -- Anticholinergics promote neuroleptic-induced tardive dyskinesia / Richard L. Borison and Bruce I. Diamond -- Receptor plasticity: biochemical correlates and pharmacological significance / E. Costa -- Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion / Lucio Annunziato, Aldo Quattrone, Gennaro Schettini, and Gianfranco Di Renzo -- Effects of neuroleptics on neuroendocrine mechanisms for gonadotropin secretion / E.E. Muller, G.B. Fregnan, T. Chieli, D. Cocchi, C. Frigerio, and V. Locatelli -- Alteration of prolactin secretion by centrally acting drugs / G.M. Besser, T. Yeo, G. Delitala, and A.B. Grossman -- Long-term effect of neuroleptics on corticosterone septo-hippocampal uptake in rats / L. Angelucci, P. Valeri, M. Palmery, and F. Patacchioli -- Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Relations to psychopathology / Dieter Naber, Manfred Ackenheil, and Gregor Laakmann -- A pharmacological analysis of the role of the amygdala in the control of gonadotropin and prolactin secretion / F. Piva, L. Martini, and M. Motta."@en ;
   schema:description "Kainic acid and neurotransmitter interactions in the basal ganglia / P.L. McGeer, E.G. McGeer, and V.T. Innanen -- Effects of chronic treatment with 1-sulpiride and haloperidol on central monoaminergic mechanisms / Kjell Fuxe, Sven-Ove Ogren, Hakan Hall, Luigi F. Agnati, Kurt Andersson, Christer Kohler, and R. Schwarcz -- Effect of the new gamma -- aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations / C. Bartholini, B. Scatton, and B. Zivkovic -- Rapid development of hypersensitivity and hyposensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in CNS / A.R. Cools -- Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons / J.S. Hong, H.-Y.T. Yang, J.C. Gillin, and E. Costa -- The role of gabba -- aminobutyric acid in acute and chronic neuroleptic action / J. Scheel-Kruger and A.V. Christensen -- Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs / F. Moroni, F. Casamenti, S. Caliari, G. Pisani, G. Moneti, and G. Pepeu -- Sustained gabba -- aminobutyric acid receptor stimulation and chronic neuroleptic effects / K.G. Lloyd and P. Worms."@en ;
   schema:description "Regulation of tyrosine hydroxylase after chronic treatment with classical and atypical antischizophrenic drugs / A. Guidotti -- Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase / W. Lovenberg, L. Alphs, S. Pradhan, E. Bruckwick, and R. Levine -- Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors / G. Biggio, M. Casu, V. Klimek, and G.L. Gessa -- Effects of chronic neuroleptic treatment on tyrosine-hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance / Karen Gale -- Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain / B. Scatton -- Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity / Maurizio Raiteri, Franca Cerrito, Gianna Casazza, and Giulio Levi -- Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment / G. Racagni, F. Bruno, A. Bugatti, M. Parenti, J.A. Apud, V. Santini, A. Carenzi, A. Groppetti, and F. Cattabeni."@en ;
   schema:description "3H-apomorphine receptors in various rat brain regions: a study of specific and non-specific binding and the influence of chronic neuroleptic treatment / Josee E. Leysen -- Involvement of calmodulin in the modulation of dopamine receptor function / I. Hanbauer and W. Phyall -- Modulation of [beta]-adrenergic receptors and calmodulin following acute and chronic treatment with neuroleptics / Benjamin Weiss and Louise H. Greenberg -- Calmodulin release from striatal membranes after acute and chronic treatment owth butaclamol / M.E. Gnegy and Y.S. Lau -- Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs / Alice M. Marshall nd Ram K. Mishra -- Radioreceptor labeling of pre- and post-synaptic dopamine receptors / Milt Titeler and Philip Seeman -- No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics / John Hyttel -- Dopamine receptor blockade in rat brain after acute and subchronic treatment with tricyclic antidepressants / H.H. Keller, W.P. Burkard, and M. Da Prada -- Attempts to develop super- or subsensitivity of retinal dopamine receptors after various treatments in antagonists or agonists / Pierre J. Magistretti and Michel Schorderet."@en ;
   schema:description "Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies / N.P.V. Nair, S. Lal, G. Schwartz, and J.X. Thavundayil -- Effect of serotonin on prolactin secretion in vitro / G. Delitala, T. Yeo, W.A. Stubbs, Ann Jones, and G.M. Besser -- Inhibition of sulpiride-induced prolactin secretion by dihydroergocristine in man / M. Poli, F. Caviezel, A.M. Girardi, E. Bosi, and G. Pozza -- The pathophysiologic basis of tardive dyskinesia / Ross J. Baldessarini and Daniel Tarsy -- Pharmacologic studies of tardive dyskinesia / Thomas N. Chase and Carol A. Tamminga -- Use of choline and lecithin in the treatment of tardive dyskinesia / Steven H. Zeisel, Alan J. Gelenberg, John H. Growdon, and Richard J. Wurtman -- Use of survival curves in analysis of antipsychotic relapse studies / John M. Davis, Maurice W. Dysken, Shelby J. Haberman, Javaid I. Javaid, Sidney S. Chang, and Grant A. Killian -- Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study / Jerome Levine, Nina R. Schooler, Joanne Severe, Javier Escobar, Alan Gelenberg, Michel Mandel, Robert Sovner, and Richard Steinbook."@en ;
   schema:description "Long-term effects of haloperidol, clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics / Herbert Ladinsky, Silvana Consolo, Rosario Samanin, Sergio Algeri, and Franca Ponzio -- Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity / Benjamin S. Bunney, Lana Skirboll, and Anthony A. Grace -- Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors / M. Trabucchi, M. Memo, F. Battaini, A. Reggiani, and P.F. Spano -- Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain / Ram B. Rastogi, Yvon D. Lapierre, Radhey L. Singhal, and N.P.V. Nair -- Long-term application of heloperidol: effect of anticholinergic treatment on the rate of dopamine-synthesis / G. Stock, P. Kummer, and J. Steinbrenner -- Neuropharmacological and neurochemical approaches to preclinical evaluation of neuroleptics / V.V. Zakusov -- The behavioral consequences of long-term treatment with neuroleptic drugs / Susan D. Iversen, R.B. Howells, and R.P. Hughes -- Brain monoamines in the rhesus monkey during long-term neuroleptic administration / Kathleen S. Shannak and Oleh Hornykiewcz -- Dopaminergic abnormalities in post-mortem schizophrenic brain / A.V.P. Mackay, E.D. Bird, L.L. Iversen, E.G. Spokes, I. Creese, and S.H. Snyder -- Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal / A. Clow, A. Theodorou, P. Jenner, and C.D. Marsden."@en ;
   schema:description "Changes in cerebral dopamine metabolism and receptors during one year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia / A. Clow, P. Jenner, A. Theodorou, and C.D. Marsden -- Drug effects on pre- and postsynaptic dopamine receptors / Nils-Erik Anden and Maria Grabowska-Anden -- Adaptive changes of the striatal dopamine system induced by repeated adminstration of neuroleptics and ergot derivatives / H.R. Burki -- Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists / Pavel Muller, Torgny H. Svensson, and Arvid Carlsson -- Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal rich areas / L.F. Agnati, K. Andersson, K. Fuxe, F. Benfenati, P. Cortelli, R. D'Alessandro, and S.-O. Ogren -- Dopamine receptor: from synaptic membranes to solubilization / Pierre Laduron -- Chronic neuroleptic treatment and dopamine receptor regulation / Ian Creese and Solomon H. Snyder -- Neuroleptic/dopamine receptors: elevation and reversal Stephen List and Philip Seeman -- Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment / Yvonne Clement-Cormier -- Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS / P.F. Spano, M. Memo, S. Govoni, and M. Trabucchi."@en ;
   schema:description "Plasma levels and therapeutic efficacy of fluphenazine hydrochloride and decanoate / Maurice W. Dysken, Sidney S. Chang, Charles Schaffer, Regina C. Casper, Javaid I. Javaid, and John M. Davis -- Measurement of fluphenazine by gas chromatography in human plasma and red blood cells / J.I. Javaid, H. Dekirmenjian, M. Dysken, and J.M. Davis -- Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration / O.T. Phillipson, J. Baker, and M. Williams -- Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate / D.H. Wiles and M.G. Gelder -- Problems of drug treatment of mental disorders / F.E. Vartanian."@en ;
   schema:description "Dopamine antagonist and agonist treatment of tardive dyskinesia / N. Bjorndal, D. Casey, and J. Gerlach -- Factors determining patient tenure on a three year double blind investigation of pimozide vs fluphenazine HCI / F.S. Abuzzahab, Sr. and R.L. Zimmermann -- A neuropharmacological and neurodendocrine study on idiopathic and chronic pharmacological parkinsonism / A. Agnoli, S. Ruggieri, P. Falaschi, M. Baldassarre, R. D'Urso, C. Forchetti, and A. Polleri -- Twelve years' experience with the total use of depot neuroleptics in a defined population / Hugh Freeman -- Reclassification of the tardive dyskinesia syndrome / T.R.E. Barnes, T. Kidger, T. Trauer, and P. Taylor -- Correlation between daily dosage of chlorpromazine and subsequent supersensitivity / Harold L. Klawans, Paul Carvey, Ana Hitri, Paul A. Nausieda, and William J. Weiner -- Huntington's disease: clinical effects of a short-term treatment with pimozide / R. Arena, A. Iudice, P. Virgili, P. Moretti, and G. Menchetti -- [gamma]-acetylenic GABA in tardive dyskinesia / Daniel E. Casey, Jes Gerlach, Gerhard Magelund, and Torben Rosted Christensen."@en ;
   schema:description "Time course of the antipsychotic effect in schizophrenia and some changes in post-mortem brain and their relation to neuroleptic medication / T.J. Crow, A.J. Cross, E.C. Johnstone, A. Longden, F. Owen, and R.M. Ridley -- Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs / Palle Kristjansen -- Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and non-human primates / Robert H. Roth, Nicholas G. Bacopoulos, Gonzalo Bustos, and D. Eugene Redmond, Jr. -- Relationships among biochemical, clinical, and pharmacokinetic variables in neuroleptic treated schizophrenic patients / Goran Sedvall -- Haloperidol plasma levels monitoring in psychiatric patients / P.L. Morselli, E. Zarifian, H. Cuche, G. Bianchetti, M.J. Cotterau, and P. Deniker -- Short- and long-term effects on GABA and dopamine neurons during treatment with sulpiride / R. Zimmer, A.W. Teelken, H. Cramer, M. Ackenheil, K.J. Zander, and H. Fischer."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/111510723> ;
   schema:genre "Conference papers and proceedings"@en ;
   schema:genre "Congresses"@en ;
   schema:genre "Conference proceedings"@en ;
   schema:genre "Conference publication"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/111510723#Series/advances_in_biochemical_psychopharmacology> ; # Advances in biochemical psychopharmacology ;
   schema:name "Long-term effects of neuroleptics"@en ;
   schema:productID "6221899" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/6221899#PublicationEvent/new_york_raven_press_1980> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/111510723#Agent/raven_press> ; # Raven Press
   schema:workExample <http://worldcat.org/isbn/9780890044056> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/6221899> ;
    .


Related Entities

<http://dbpedia.org/resource/New_York_City> # New York
    a schema:Place ;
   schema:name "New York" ;
    .

<http://experiment.worldcat.org/entity/work/data/111510723#Person/cattabeni_flaminio> # Flaminio Cattabeni
    a schema:Person ;
   schema:familyName "Cattabeni" ;
   schema:givenName "Flaminio" ;
   schema:name "Flaminio Cattabeni" ;
    .

<http://experiment.worldcat.org/entity/work/data/111510723#Series/advances_in_biochemical_psychopharmacology> # Advances in biochemical psychopharmacology ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/6221899> ; # Long-term effects of neuroleptics
   schema:name "Advances in biochemical psychopharmacology ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/111510723#Topic/antipsychotic_agents_pharmacology> # Antipsychotic Agents--pharmacology
    a schema:Intangible ;
   schema:name "Antipsychotic Agents--pharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/111510723#Topic/neuroleptiques_pharmacocinetique_congres_comme_sujet> # Neuroleptiques--Pharmacocinétique--Congrès comme sujet
    a schema:Intangible ;
   schema:name "Neuroleptiques--Pharmacocinétique--Congrès comme sujet"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/111510723#Topic/neuropsychopharmacologie_congres> # Neuropsychopharmacologie--Congrès
    a schema:Intangible ;
   schema:name "Neuropsychopharmacologie--Congrès"@fr ;
    .

<http://id.loc.gov/authorities/subjects/sh85136865> # Tranquilizing drugs
    a schema:Intangible ;
   schema:name "Tranquilizing drugs"@en ;
    .

<http://id.worldcat.org/fast/1036504> # Neuropsychopharmacology
    a schema:Intangible ;
   schema:name "Neuropsychopharmacology"@en ;
    .

<http://id.worldcat.org/fast/1154491> # Tranquilizing drugs
    a schema:Intangible ;
   schema:name "Tranquilizing drugs"@en ;
    .

<http://viaf.org/viaf/155405496> # Fondazione internazionale Menarini.
    a schema:Organization ;
   schema:name "Fondazione internazionale Menarini." ;
    .

<http://worldcat.org/isbn/9780890044056>
    a schema:ProductModel ;
   schema:isbn "0890044058" ;
   schema:isbn "9780890044056" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.